中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
[(2,5-二氧代-4-戊基-咪唑烷-4-基)亚甲基氨基]脲 |
[(E)-(2,5-dioxo-4-pentylimidazolidin-4-yl)methylideneamino]urea |
6974-21-6 |
C10H17N5O3 |
|
[(2,5-二氧代-4-戊基-咪唑烷-4-基)亚甲基氨基]硫脲 |
[(E)-(2,5-dioxo-4-pentylimidazolidin-4-yl)methylideneamino]thiourea |
5454-69-3 |
C10H17N5O2S |
|
[(2,5-二氧代-4-丙基-咪唑烷-4-基)亚甲基氨基]脲 |
[(E)-(2,5-dioxo-4-propylimidazolidin-4-yl)methylideneamino]urea |
6974-19-2 |
C8H13N5O3 |
|
[(2,4-二氯苯基)肼基]氯乙酸乙酯 |
ethyl chloro[(2,4-dichlorophenyl)hydrazono]acetate |
27143-12-0 |
C10H9Cl3N2O2 |
|
[(1aR,3S,4Z,5aR,8aR,9R,10aR)-1a,2,3,5a,7,8,8a,9,10,10alpha-十氢-3-羟基-4,10alpha-二甲基-8-亚甲基-7-氧代环氧乙烷并[5,6]环癸[1,2-b]呋喃-9-基]2-甲基丙烯酸酯 |
Erioflorin |
27542-17-2 |
C19H24O6 |
|
[(1S,4R,6R)-1,5,5-三甲基-6-双环[2.2.1]庚烷基]乙酸酯 |
exo-fenchyl acetate |
76109-40-5 |
C12H20O2 |
|
[(1S,3S)-3-异丙烯基-1-甲基-2-亚甲基环戊基]乙酸乙酯 |
ethyl [(1S,3S)-3-isopropenyl-1-methyl-2-methylenecyclopentyl]acetate |
581096-83-5 |
C14H22O2 |
|
[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(二苯基氨基)羰基]十二氢-1-甲基-3-氧代萘并[2,3-c]呋喃-6-基]氨基甲酸乙酯 |
Ethyl ((1R,3aR,4aR,6R,8aR,9S,9aS)-9-(diphenylcarbamoyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
900161-12-8 |
C29H34N2O5 |
|
[(1E)-6-羟基-1-己烯-1-基]硼酸 |
(E)-6-hydroxyhex-1-en-ylboronic acid |
132047-94-0 |
C6H13BO3 |
|
[(1E)-4-溴-1-丁烯-1-基]苯 |
(E)-(4-bromobut-1-en-1-yl)benzene |
7515-41-5 |
C10H11Br |
|
[(1,1-二甲基乙基)亚磺酰]乙酸乙酯 |
ethyl tert-butylsulfinyl acetate |
57475-09-9 |
C8H16O3S |
|
Ethyl 5-氨基-4-氰基-3-甲基-2-噻吩羧酸乙酯 |
ethyl 5-amino-4-cyano-3-methylthiophene-2-carboxylate |
23903-46-0 |
C9H10N2O2S |
|
Esomeprazole镁盐水合物 |
(S)-Omeprazole magnesium;(-)-Omeprazole magnesium |
668985-31-7 |
C34H38MgN6O7S2 |
|
Erythristemine; (3beta,11alpha)-1,2,6,7-四去氢-3,11,15,16-四甲氧基刺桐烷 |
(+/-)-erythristemine |
28619-41-2 |
C20H25NO4 |
|
ErythrininC;2,3-二氢-4-羟基-2-(1-羟基-1-甲基乙基)-6-(4-羟基苯基)-5H-呋喃并[3,2-g][1]苯并吡喃-5-酮 |
erythrinin C |
63807-85-2 |
C20H18O6 |
|
Erysotramidine; (3beta)-1,2,6,7-四去氢-3,15,16-三甲氧基刺桐烷-8-酮 |
(+)-erysotramidine |
52358-58-4 |
C19H21NO4 |
|
Ervamycine; 11-甲氧基水甘草碱 |
11-methoxytabersonine |
27773-39-3 |
C22H26N2O3 |
|
Emixustat盐酸盐 |
emixustat hydrochloride |
1141934-97-5 |
C16H25NO2*ClH |
|
Elacestrant 二盐酸盐 |
Elacestrant hydrochloride |
1349723-93-8 |
C30H40Cl2N2O2 |
|
Egenine; (6R,8S)-6,8-二氢-6-[(5S)-5,6,7,8-四氢-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基]呋喃并[3,4-e]-1,3-苯并二氧杂环戊烯-8-醇 |
(+)-egenine |
6883-44-9 |
C20H19NO6 |
|
Eg5抑制剂VII |
6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-quinolin-2-one |
912953-25-4 |
C16H12F3NO |
|
Eg5抑制剂IV,VS-83 |
Eg5 Inhibitor IV, VS-83 |
909250-29-9 |
C14H11FN2OS |
|
EZH2甲基转移酶抑制剂(GSK126) |
GSK-126 |
1346574-57-9 |
C31H38N6O2 |
|
EZATIOSTAT游离的 |
γ-glutamyl-S-(benzyl)cysteinyl-(R)-(-)-phenylglycine diethyl ester |
168682-53-9 |
C27H35N3O6S |
|
EVACETRAPIB中间体 |
methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetra-hydro-1H-benzo[b]azepine-1-carboxylate |
1259393-27-5 |
C14H17NO3 |
|
ETHYL4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-1-THIO-Β-D-GLUCOPYRANOSIDE乙基4,6-O-亚苄基-2-脱氧-2-邻苯二甲酰亚氨基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside |
99409-33-3 |
C23H23NO6S |
|
ETHYL3-O-(2-NAPHTHYL)METHYL-4,6-O-BENZYLIDENE-1-THIO-Β-D-GLUCOPYRANOSIDE乙基3-O-(2-萘基)甲基-4,6-O-亚苄基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside |
352008-09-4 |
C26H28O5S |
|
ETHYL 5-硝基-2-吡啶乙基甲苯 |
ethyl 5-nitropicolinate |
30563-98-5 |
C8H8N2O4 |
|
ESTRATETRAENONE甲酯 |
Equilin 3-methyl ether |
6030-83-7 |
C19H22O2 |
|
ERRΒ/Γ激动剂(GSK-4716) |
(E)-N'-(4-(diethylamino)benzylidene)-4-hydroxybenzohydrazide |
95167-41-2 |
C18H21N3O2 |
|
ERK抑制剂II,阴性对照 |
ERK Inhibitor II, Negative Control |
1177970-73-8 |
C18H12N6O |
|
EPZ005687抑制剂 |
EPZ005687 |
1396772-26-1 |
C32H37N5O3 |
|
EPSILON-(GAMMA-L-谷氨酰)-L-赖氨酸 |
epsilon-(gamma-glutamyl)lysine |
17105-15-6 |
C11H21N3O5 |
|
EPA乙酯 |
Methyl (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoate |
28061-46-3 |
C23H34O2 |
|
EPA乙酯 |
eicosapentaenoic acid ethyl ester |
86227-47-6 |
C22H34O2 |
|
ENT-甲磺酸帕珠沙星 |
ent-Pazufloxacin Mesylate |
677004-96-5 |
C17H19FN2O7S |
|
ENT-他达拉非 |
(+/-) cis-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
629652-72-8 |
C22H19N3O4 |
|
ENS-163磷酸盐 |
ENS-163 phosphate |
117707-51-4 |
C11H19N2O5PS |
|
ENDOGLYCOSIDASEF2来源于脑膜炎脓毒性黄杆菌 |
mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase |
37278-88-9 |
—— |
——
|
EMT抑制剂-1 |
4-((4-(3,4-dichlorophenyl)-1,2,5-thiadiazol-3-yl)oxy)butan-1-ol |
1638526-21-2 |
C12H12Cl2N2O2S |
|
EMPAGLIFLOZIN杂质104 |
(5-chloro-2-iodophenyl)(2-fluorophenyl)methanone |
76049-49-5 |
C13H7ClFIO |
|
EMD638683 (形态 S); (alphaS)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 |
N'-[(S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide |
1184940-46-2 |
C18H18F2N2O4 |
|
EMD638683 (形态 R); (alphaR)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 |
N'-[(R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide |
1184940-47-3 |
C18H18F2N2O4 |
|
EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 |
tepotinib |
1100598-32-0 |
C29H28N6O2 |
|
EMD 534085; N-[2-(二甲基氨基)乙基]-N'-[[(2R,4aS,5R,10bS)-3,4,4a,5,6,10b-六氢-5-苯基-9-(三氟甲基)-2H-吡喃并[3,2-c]喹啉-2-基]甲基]脲 |
EMD 534085 |
858668-07-2 |
C25H31F3N4O2 |
|
ELA锁链素 |
4-(16-(S)-amino-16-carboxybutyl)-1-(11-(S)-amino-11-carboxypentyl)-3,5-bis-(20,20’-(S)-amino-20,20’-carboxypropyl)pyridinium |
11003-57-9 |
C24H40N5O8 |
|
EIPA盐酸盐 |
ethylisopropyl amiloride hydrochloride |
1345839-28-2 |
C11H18ClN7O*ClH |
|
EGFR抑制剂 |
EGFR Inhibitor |
879127-07-8 |
C21H18F3N5O |
|
EGFR-IN-9(化合物8) |
N-{3-[4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]-pyrimidin-5-yl]phenyl}acrylamide |
1226549-39-8 |
C29H24N4O3 |
|
EED抑制剂(EEDINHIBITOR-1) |
MAK683 |
1951408-58-4 |
C20H17FN6O |
|